Molecular Oncology · 2017 · 42 citations · 38 references
MedicineCell BiologyOncologyCell AdhesionMetastasisMolecular OncologyCancer Cell SignalingCell Adhesion AlterationsCell MigrationCell-matrix AdhesionIntegrin SignalingMetastatic Signaling PathwaysActin DynamicsActin Polymerization DynamicsIntegrin-mediated MotilityMetastasis Of Prostate CancerRac1 SignalingRho Family Gtpase SignalingRho Family GtpasesTumor Cell Motility
Experimental and clinical evidence suggests that N-myc downregulated gene 1 (NDRG1) functions as a suppressor of prostate cancer metastasis. Elucidating pathways that drive survival and invasiveness of NDRG1-deficient prostate cancer cells can help in designing therapeutics to target metastatic prostate cancer cells. However, the molecular mechanisms that lead NDRG1-deficient prostate cancer cells to increased invasiveness remain largely unknown. In this study, we demonstrate that NDRG1-deficient prostate tumors have decreased integrin expression and reduced cell adhesion and motility. Our data indicate that loss of NDRG1 differentially affects Rho GTPases. Specifically, there is a downregulation of active RhoA and Rac1 GTPases with a concomitant upregulation of active Cdc42 in NDRG1-deficient cells. Live cell imaging using a fluorescent sensor that binds to polymerized actin revealed that NDRG1-deficient cells have restricted actin dynamics, thereby affecting cell migration. These cellular and molecular characteristics are in sharp contrast to what is expected after loss of a metastasis suppressor. We further demonstrate that NDRG1-deficient cells have increased resistance to anoikis and increased invasiveness which is independent of its elevated Cdc42 activity. Furthermore, NDRG1 regulates expression and glycosylation of EMMPRIN, a master regulator of matrix metalloproteases. NDRG1 deficiency leads to an increase in EMMPRIN expression with a concomitant increase in matrix metalloproteases and thus invadopodial activity. Using a three-dimensional invasion assay and an in vivo metastasis assay for human prostate xenografts, we demonstrate that NDRG1-deficient prostate cancer cells exhibit a collective invasion phenotype and are highly invasive. Thus, our findings provide novel insights suggesting that loss of NDRG1 leads to a decrease in actin-mediated cellular motility but an increase in cellular invasion, resulting in increased tumor dissemination which positively impacts metastatic outcome.
38
Lifeact: a versatile marker to visualize F-actin
Julia Riedl, Álvaro H. Crevenna, Kai Kessenbrock et al. · Nature Methods · 2008 · 2.3K citations · Full text
MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL
Conor C. Lynch, Atsuya Hikosaka, Heath B. Acuff et al. · Cancer Cell · 2005 · 388 citations · Full text
Medicine, Cancer Biology, Oncology +14